ライフサイエンスコーパス: adenosine

1 and hydrolysis of ATP, cAMP, AMP, and NAD to adenosine.

2 MBF to the same level as a standard dose of adenosine.

3 te than resting indices and does not require adenosine.

4 with the 5' splice site and the branch-point adenosine.

5 on MBF due to hypercapnia was compared with adenosine.

6 nitive performance do not explicitly include adenosine.

7 hancing the production of the ATP derivative adenosine.

8 increase in the generation of extracellular adenosine.

9 A binding tunnel that typically contains the adenosine 2'OH of the RNA-cap moiety.

10 t requires the following: Gs-protein-coupled adenosine 2A receptor activation, new TrkB synthesis, an

11 tection from IRI through bone marrow-derived adenosine 2a receptors.

12 th pharmacological and genetic inhibition of adenosine-2A receptor (A2AR) in culture and Lrp4 mutant

13 endent activating transcription factor (ATF)-adenosine 3',5'-monophosphate (cAMP) response element-bi

14 The cyclic adenosine 3',5'-monophosphate receptor protein (CAP), a

15 displayed reduced aggregation in response to adenosine 5'-diphosphate and epinephrine, but variable a

16 numerous agonists (collagen-related peptide, adenosine 5'-diphosphate, A23187, thrombin, or U46619).

17 negative and positive allosteric regulators, adenosine 5'-monophosphate (AMP) and fructose 1,6-bispho

18 tivity was stimulated to a greater extent by adenosine 5'-O-(thiotriphosphate) (ATPgammaS) than with

19 of the sulfate reductive pathway key enzyme, adenosine 5'-phosphosulfate reductase (APR, EC 1.8.99.2)

20 The adenosine 6-minute infusion with rubidium-82 injection a

21 ins alter gene expression both by catalyzing adenosine (A) to inosine (I) RNA editing and binding to

22 Adenosine, a key extracellular signaling mediator, regul

23 ce of heterosynaptic plasticity; blockade of adenosine A1 receptors abolished it.

24 ncreases the concentrations of adenosine and adenosine A1 receptors in specific regions of the brain.

25 inoid receptors present in the striatum, ie, adenosine A2A receptor (A2AR) and cannabinoid CB1 recept

26 e describe the spontaneous reconstitution of adenosine A2A receptor (A2AR) during the de novo formati

27 The adenosine A2A receptor (A2AR) has long been implicated i

28 e reduced oxygen-induced neural apoptosis by adenosine A2A receptor (A2AR)-dependent mechanism, as re

29 sity and morphology, and upregulation of the adenosine A2A receptor (A2AR).

30 Here, we show that the adenosine A2a receptor (ADORA2A) promotes hypoxia-induci

31 esulted in discovery of potent and selective adenosine A2A receptor antagonists bearing substituted 1

32 s- and Golf-coupled dopamine D1 receptor and adenosine A2A receptor in the brain and other organs, el

33 The cerebral adenosine A2A receptor is an attractive therapeutic targ

34 ntially therapeutic dopamine D1 receptor and adenosine A2A receptor ligands with functionally selecti

35 2 (CK2) negatively regulates dopamine D1 and adenosine A2A receptor signaling in the striatum.

36 ha), from dopamine D1 receptor-expressing or adenosine A2a receptor-expressing medium spiny neurons (

37 on of Th1 and Th2 cells in vitro depended on adenosine A2A receptors, which were also required for th

38 [2,1-f]purine-2,4-dione derivatives as human adenosine A3 receptor (hA3R) antagonists to determine th

39 ic state of this RNA shows guanosine G40 and adenosine A32 close to the G53-U54 cleavage site.

40 Adenosine/adenosine receptor-mediated signaling has been

41 In this work, we show that adenosine (ADO), which is a potent endogenous modulator,

42 hod for determining specificity of synthetic adenosine agonist compounds for the A2A and A2B receptor

43 and allowing us to isolate the most specific adenosine agonist compounds.

44 ts, the stable 3-deaza-3-methoxynaphtylethyl-adenosine analog (3d-Napht-A), and smaller 3-deaza-adeno

45 ine analog (3d-Napht-A), and smaller 3-deaza-adenosine analogs, into DNA oligonucleotides to assess R

46 to test the hypothesis that changes in both adenosine and A1 receptor concentrations can capture cha

47 ttern implies that differences in endogenous adenosine and A1AR availability might be causal for indi

48 airments and increases the concentrations of adenosine and adenosine A1 receptors in specific regions

49 Specifically, the main adenosine and endocannabinoid receptors present in the s

50 Adenosine and functional A1 adenosine receptor (A1AR) av

51 that generate similar voltammograms, such as adenosine and histamine.

52 Mean perfusion defect volumes measured with adenosine and hypercapnia were significantly correlated

53 te, adenosine monophosphate) and nucleoside (adenosine and inosine) levels were quantified by high-pe

54 with endogenous activators of PKA, including adenosine and prostaglandin E2, results in a profound de

55 the quantum yield of 8-DEA-tC mispaired with adenosine and, separately, opposite an abasic site show

56 ridine monophosphate, inosine monophosphate, adenosine, and guanosine) and kokumi (gamma-l-glutamyl-l

57 tinal tract and unveil an important role for adenosine as a regulator of host-microbe interactions.

58 sition for nucleophilic attack of the branch adenosine at the 5' splice site.

59 osition that overlaps with the native ligand adenosine, but its methoxyphenyl group extends to an exo

60 This study tested whether adenosine caused prolonged asystole after transplantatio

61 subject, (3) stress perfusion and CFR after adenosine compared with dipyridamole, (4) heterogeneity

62 nes, and adenosine injection increased urine adenosine concentration and decreased urine pH.

63 Here we show that, apart from NAD+, another adenosine-containing cofactor FAD and highly abundant ur

64 Deficiency of adenosine deaminase 2 (DADA2) is caused by biallelic del

65 e repair, we exploit the catalytic domain of Adenosine Deaminase Acting on RNA (ADAR2) that deaminate

66 AC)7 with the Zalpha-binding domain of human adenosine deaminase acting on RNA 1 (ADAR1, hZalphaADAR1

67 n directly inhibits editing, we do show that adenosine deaminase acting on RNA 1 and 2 and fibrillari

68 sine-to-inosine deaminase activity by ADAR2 (adenosine deaminase acting on RNA type 2) to transcripts

69 In this study, we identify adenosine deaminase that acts on RNA 3 (ADAR3) as an imp

70 eic HSCT that has shown clinical benefit for adenosine deaminase-deficient (ADA-deficient) SCID when

71 o-inosine (A-to-I) RNA editing, catalyzed by Adenosine DeAminases acting on double-stranded RNA(dsRNA

72 ADAR1 isoforms are adenosine deaminases that edit and destabilize double-st

73 Adenosine diphosphate (ADP) enhances platelet activation

74 ownregulate the adenosine triphosphate (ATP)/adenosine diphosphate (ADP) metabolite ratio which stron

75 sphate (ATP) and its first five catabolites: adenosine diphosphate (ADP), adenosine monophosphate (AM

76 Protein adenosine diphosphate (ADP)-ribosylation is a physiologi

77 e redox potential and adenosine triphosphate/adenosine diphosphate failed to reach a new steady state

78 uent use of radial access and novel platelet adenosine diphosphate P2Y12 receptor inhibitors.

79 2365 patients enrolled in the Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal

80 It metabolizes NAD(+) to adenosine diphosphate ribose (ADPR) and cyclic ADPR, reg

81 Nucleotide (ATP, adenosine diphosphate, adenosine monophosphate) and nucl

82 Soluble apyrase reduced renal ATP, adenosine diphosphate, and adenosine monophosphate, but

83 Cangrelor is a potent intravenous adenosine diphosphate-receptor antagonist that in the CH

84 r 1) prevents it from inhibiting PARP1 [poly(adenosine diphosphate-ribose) polymerase], a critical DN

85 Prevention of generation of adenosine diphosphoribose in ECs significantly reduced C

86 Overexpression of the adenosine diphosphoribose insensitive TRPM2 mutant chann

87 y in response to intracellular generation of adenosine diphosphoribose-the TRPM2 ligand.

88 The effects of patient characteristics on adenosine dose required to produce atrioventricular bloc

89 t characteristic significantly predicted the adenosine dose to produce atrioventricular block or dura

90 e mRNA level, a disease-causing guanosine to adenosine (G > A) mutation in the mouse MeCP2 DNA bindin

91 These data support the thesis that local adenosine generated by cells at the injury site is criti

92 denosine levels supported a critical role of adenosine generated by proximal tubule CD73 expression i

93 Extracellular adenosine generated by the ectonucleotidases CD39 and CD

94 etin and its isomer, while its reaction with adenosine generated kinetin riboside, as confirmed by co

95 cleotidases that control ATP degradation and adenosine generation.

96 We show that adenosine harbors bacteriostatic activity against Salmon

97 Adenosine has been implicated in pathways that generate

98 ew versatile scaffold for the development of adenosine human (h) receptor antagonists.

99 aCO2) can increase MBF to that observed with adenosine in 3 groups of canines: without coronary steno

100 ding, respectively, and it was decoded as an adenosine in both systems.

101 the pro- and anti-viral effects of methyl-6-adenosine in distinct viral life cycles, the role of 2'

102 ression, reducing the level of intracellular adenosine in endothelial cells, and activating the trans

103 nce exists for the role of immunosuppressive adenosine in promoting tumor growth and spread in a numb

104 we define a novel antimicrobial activity of adenosine in the gastrointestinal tract and unveil an im

105 Therefore, we investigated the role of adenosine in the regulation of V-ATPase in ICs.

106 Editing of one adenosine in the transcript encoding the glutamate recep

107 was a close agreement of maximal saline- and adenosine-induced coronary flow reserve (intraclass corr

108 ography scans using rubidium-82 with various adenosine infusion protocols identified (1) the protocol

109 The 6-minute adenosine infusion with rubidium-82 activation at 3 minu

110 significantly 15.7% higher than the 4-minute adenosine infusion with rubidium-82 injection at 2 minut

111 rs are located in A-IC apical membranes, and adenosine injection increased urine adenosine concentrat

112 Adenosine is a Food and Drug Administration-approved dru

113 As adenosine is known to cause changes in intracellular cal

114 ing the stem leads to destabilization unless adenosine is the opposing basepair of 8-oxoGua; (ii) mod

115 ucleotidase (CD73), an enzyme that generates adenosine, is functionally important in modifying CB sen

116 al CO2 (PaCO2), particularly with respect to adenosine, is not well characterized because of challeng

117 Here we show that concentrations of ATP and adenosine, its metabolite, fall after treatment of mouse

118 In contrast, the adenosine kinase inhibitor, 5-iodotubericidin, which inh

119 We found different adenosine kinase-inactivating (ADK-inactivating) alterat

120 We report that in healthy lowlanders, plasma adenosine levels are rapidly induced by initial ascent t

121 ent studies showed no change in total kidney adenosine levels in treated mice compared with vehicle-t

122 enzymatic activity of CD73 and extracellular adenosine levels supported a critical role of adenosine

123 Renal adenosine levels were lower before and after ischemia in

124 sphate, and adenosine monophosphate, but not adenosine levels, during ischemia.

125 stream metabolic changes, such as increasing adenosine levels, which might have effects on seizure co

126 report that methylation at the 6 position of adenosine (m(6)A) in RNA is rapidly (within 2 min) and t

127 on of a methyl group to the N(6) position of adenosine (m(6)A), has been shown to affect splicing, tr

128 ified by methylation of the N(6) position of adenosine (m(6)A).

129 '-deadenylation activity, suggesting that 3'-adenosine may occupy the ATP-binding pocket.

130 N6-adenosine methylation (m(6) A) of mRNA is an essential p

131 We demonstrate that the N(6)-adenosine methyltransferase METTL16 regulates expression

132 6.0 Kcal/mole and for all of them the edited adenosines mis-paired with cytosines on the pre-miRNA st

133 We speculate that adenosine modulation may provide a mechanism for fine-tu

134 otein 1 (PABP1) were covalently linked to an adenosine moiety as in the AdoMet cofactor to generate t

135 e nucleotide signaling molecule 3',5'-cyclic adenosine monophosphate (3',5'-cAMP) plays important phy

136 ve catabolites: adenosine diphosphate (ADP), adenosine monophosphate (AMP), inosine monophosphate (IM

137 Cyclic di-3',5'-adenosine monophosphate (c-di-AMP) is a broadly conserve

138 Cyclic adenosine monophosphate (cAMP) and protein kinase A (PKA

139 udies exploring the importance of the cyclic adenosine monophosphate (cAMP) cascade in major depressi

140 bunit through formation of a PDE-PKAR-cyclic adenosine monophosphate (cAMP) complex (the termination

141 phodiesterase (PDE4) and elevation of cyclic adenosine monophosphate (cAMP) has emerged as a promisin

142 Cyclic adenosine monophosphate (cAMP) is an important mediator

143 Intracellular cyclic adenosine monophosphate (cAMP) levels tune the voltage r

144 were treated with Angiopoietin 1 and cyclic adenosine monophosphate (cAMP) to vary the Pd of the HUV

145 f phenylalanine, acetylhistidine, and cyclic adenosine monophosphate (cAMP) were found in urine sampl

146 rmore, we demonstrated that Tregs use cyclic adenosine monophosphate (cAMP)-dependent protein kinase

147 chemotaxis towards emitted pulses of cyclic adenosine monophosphate (cAMP).

148 lutamatergic, monoaminergic, calcium, cyclic adenosine monophosphate [cAMP], dopamine- and cAMP-regul

149 culture and decidualized with 8-bromo-cyclic adenosine monophosphate and medroxyprogesterone acetate.

150 We show that cyclic-di-adenosine monophosphate in live Gram-positive bacteria i

151 n of the cardiac stress marker NR4A1; cyclic adenosine monophosphate levels; and cyclic adenosine mon

152 ional activity and phosphorylation of cyclic adenosine monophosphate response element binding protein

153 ated the functional regulation of the cyclic adenosine monophosphate response element binding protein

154 promoter region as well as increased cyclic adenosine monophosphate response element-mediated transc

155 Nucleotide (ATP, adenosine diphosphate, adenosine monophosphate) and nucleoside (adenosine and i

156 educed renal ATP, adenosine diphosphate, and adenosine monophosphate, but not adenosine levels, durin

157 5'-Adenosine monophosphate-activated protein kinase (AMPK)

158 (PTEN) induces activation of the phospho-5' adenosine monophosphate-activated protein kinase and pho

159 adou et al. report that the metabolic sensor adenosine monophosphate-activated protein kinase influen

160 rectly targets the 3' untranslated region of adenosine monophosphate-activated protein kinase subunit

161 c adenosine monophosphate levels; and cyclic adenosine monophosphate-dependent protein kinase A-media

162 ivation of neuronal EP2 receptors and cyclic adenosine monophosphate-dependent protein kinase.

163 m of ICAM-4 activation occurs via the cyclic adenosine monophosphate-protein kinase A (cAMP-PKA)-depe

164 GS-5734 is a monophosphate prodrug of an adenosine nucleoside analog that showed therapeutic effi

165 but very little is known about the effect of adenosine on IC function.

166 Intravenous treatment of mice with adenosine or agonists of ADORA2A and ADORA2B purinergic

167 xes containing AK and each of four different adenosine phosphate ligands.

168 CD73-derived adenosine plays an anti-inflammatory role in various org

169 sults suggest that controlling access to the adenosine pocket can contribute to substrate specificity

170 iprocal alterations were made to enlarge the adenosine pocket of EhACK and reduce that of MtACK.

171 njection of liposomal suspensions containing adenosine prevents development of OA in rats.

172 investigate the contribution of CD73-derived adenosine produced by T cells to cardiac remodeling afte

173 uced immunosuppressive mechanisms, including adenosine production.

174 with the 3/6-minute protocol, the 2/4-minute adenosine protocol would potentially have changed 332 of

175 Adenosine and functional A1 adenosine receptor (A1AR) availability are supposed to m

176 of compound 25 as a potent and selective A2A adenosine receptor (A2AAdoR) antagonist with reasonable

177 MR) spectroscopy with the wild-type-like A2A adenosine receptor (A2AAR) in solution provides a compre

178 Here, we show that engagement of A2A adenosine receptor (A2AR) acts as a checkpoint that limi

179 The cAMP-elevating, Gs protein-coupled A2a adenosine receptor (A2aR) is an evolutionarily conserved

180 overexpress mRNA for dopamine receptor 2 and adenosine receptor 2a in the striatum, markers of medium

181 Here the authors show that adenosine receptor A2A drives pathological angiogenesis

182 ry synapses from basolateral amygdala via A1 adenosine receptor activation and enhanced inhibitory sy

183 wild-type levels, suggesting a dependence on adenosine receptor activity.

184 The effect of inosine was mimicked by the adenosine receptor agonist NECA and the A2B receptor ago

185 le of enantiospecific recognition at the A2B adenosine receptor and opens new possibilities in ligand

186 ith the synthesis of an A2-subtype selective adenosine receptor antagonist in only two steps.

187 Caffeine (5, 10, or 15 mg/kg), a nonspecific adenosine receptor antagonist, dose-dependently and at h

188 n against OIR, effective therapeutic window, adenosine receptor mechanisms, and neuroglial involvemen

189 of BRAF and MEK in combination with the A2A adenosine receptor provided significant protection again

190 Stimulation of the adenosine receptor subtype A2B increases the gap junctio

191 ge, new cholesterol-binding sites on the A2A adenosine receptor, a G-protein-coupled receptor that is

192 MD/FEP) in fragment optimization for the A2A adenosine receptor, a pharmaceutically relevant G protei

193 at integrates gap junction coupling into the adenosine receptor-dependent signalling of endothelial c

194 ulfur phasing of the human G protein-coupled adenosine receptor.

195 tent binding across therapeutically relevant adenosine receptors (A1, A2a, and A3) as well as a poten

196 to G protein-coupled receptors including the adenosine receptors (AR), which are involved in a pletho

197 -coupled receptors, the A1, A2A, A2B, and A3 adenosine receptors (ARs).

198 characterize the physiological link between adenosine receptors and the gap junction coupling in end

199 Because each of these adenosine receptors plays a distinct role throughout the

200 These effects were mimicked by antagonism of adenosine receptors with 8-(p-sulfophenyl) theophylline.

201 or), opioid receptors, adrenergic receptors, adenosine receptors, dopamine receptor, and sphingosine

202 Here we show that adenosine regulates weight dependence of heterosynaptic

203 e, poxviruses remodel host ribosomes so that adenosine repeats erroneously generated by slippage of t

204 As with 5' untranslated regions that contain adenosine repeats, so-called polyA-leaders.

205 Adenosine replacement by intra-articular injection of li

206 , modulation of heterosynaptic plasticity by adenosine represents an endogenous mechanism that transl

207 2'-O-ribose-methylation of adenosine residues, however, has been shown to inhibit a

208 promoting neuromodulators, noradrenaline and adenosine, respectively.

209 y is active in melanoma patients and whether adenosine restricts the efficacy of clinically approved

210 t within the GC facilitates an extracellular adenosine-rich milieu, which serves to limit TFH frequen

211 ng ADORA2B have been implicated in mediating adenosine's effects in IPF.

212 ogether, our results establish A2AR-mediated adenosine signaling as an intrinsic negative regulator o

213 Previous work demonstrated that adenosine signaling in IECs results in a number of tissu

214 ed antitumor immunity.Significance: Ablating adenosine signaling is found to promote natural killer c

215 is promoted by a cross-talk between HA, CD73/adenosine signaling, and other profibrotic mediators.

216 nforcement signals, mediated by dopamine and adenosine signaling.

217 Adenosine signalling via erythrocyte ADORA2B induces PKA

218 ticularly hydrogen peroxide (H2O2), impaired adenosine stimulated wound repair.

219 ght dependence of heterosynaptic plasticity: adenosine strengthened weight dependence of heterosynapt

220 Different adenosine stress imaging protocols have not been systemi

221 were compared with those obtained during an adenosine stress test (140 mug/kg/min).

222 aluation of stable angina symptoms underwent adenosine-stress dynamic computed tomography myocardial

223 ter in a pocket surrounding the branch point adenosine, suggesting a competitive mode of action.

224 e fold but remarkably, unlike tuberculosinol adenosine synthase and other cis-prenyl transferases (e.

225 veloped a novel receptor-ligand model of the adenosine system to test the hypothesis that changes in

226 Adenosine, the standard therapy for treating supraventri

227 hows that medullary A-ICs respond to luminal adenosine through ADORA2A and ADORA2B receptors in a cAM

228 deletion allows rapid accumulation of plasma adenosine to counteract hypoxic tissue damage in mice.

229 re required for paraspeckles, as well as for adenosine to inosine (A to I) RNA editing of Ctn RNA in

230 Adenosine to Inosine (A-to-I) RNA editing is a co- or po

231 Conversion of adenosine to inosine is a frequent type of RNA editing,

232 and innate immune sensing, and functions of adenosine to inosine modifications in retroviral life cy

233 Adenosine-to-inosine (A-to-I) editing of dsRNA by ADAR p

234 of The Cancer Genome Atlas and identified 19 adenosine-to-inosine (A-to-I) RNA editing hotspots.

235 Adenosine-to-inosine (A-to-I) RNA editing is a conserved

236 Adenosine-to-inosine (A-to-I) RNA editing, catalyzed by

237 alytically inactive Cas13 (dCas13) to direct adenosine-to-inosine deaminase activity by ADAR2 (adenos

238 igate whether angiomiR miR487b is subject to adenosine-to-inosine editing or 2'-O-ribose-methylation

239 residues, however, has been shown to inhibit adenosine-to-inosine editing.

240 Since adenosine-to-inosine RNA editing has recently emerged as

241 Adenosine-to-inosine RNA editing in transcripts encoding

242 d inoFISH to directly visualize and quantify adenosine-to-inosine-edited transcripts in situ.

243 es adenosine tone) and brain state (elevated adenosine tone increases sleep pressure), modulation of

244 Because adenosine tone is a natural correlate of activity level

245 relate of activity level (activity increases adenosine tone) and brain state (elevated adenosine tone

246 c environment in the catalytic space of gp17-adenosine triphosphatase (ATPase) determines the rate at

247 y component of the system is the proteasomal adenosine triphosphatase (ATPase) Mpa, which captures, u

248 necessary for packaging in such viruses: the adenosine triphosphatase (ATPase) that powers DNA transl

249 Sarcoplasmic/endoplasmic reticulum Ca(2+) adenosine triphosphatase (SERCA)2a, a critical regulator

250 tion through inhibition of the vacuolar H(+)-adenosine triphosphatase (V-ATPase) increased the lumina

251 lectron microscopy structure reveals how the adenosine triphosphatases (ATPases) form a closed spiral

252 es are conserved members of the AAA+ family (adenosine triphosphatases associated with diverse cellul

253 a key purinergic enzyme in the hydrolysis of adenosine triphosphate (ATP) and increased CD39 enzymati

254 and accurate method for the determination of adenosine triphosphate (ATP) and its first five cataboli

255 sly showed that patients with BD show normal adenosine triphosphate (ATP) and phosphocreatine levels

256 es on host cells for essential nutrients and adenosine triphosphate (ATP) for a productive infection.

257 Here, we show that adenosine triphosphate (ATP) has properties of a biologi

258 METHOD: Mitochondrial O2 consumption and adenosine triphosphate (ATP) synthesis rates of osteosar

259 es have demonstrated that in the presence of adenosine triphosphate (ATP) the human RAD51 (HsRAD51) r

260 lectrostatic lock to prevent coordination of adenosine triphosphate (ATP) to the catalytic site.

261 ABCB4 (MDR3) is an adenosine triphosphate (ATP)-binding cassette (ABC) tran

262 re harboring disease-causing variants in the adenosine triphosphate (ATP)-binding cassette subfamily

263 plex loaded onto DNA directly interacts with adenosine triphosphate (ATP)-bound DnaA and stimulates t

264 al part of the chromatin landscape shaped by adenosine triphosphate (ATP)-dependent chromatin remodel

265 nt study, H2O2 dose-dependently impaired the adenosine triphosphate (ATP)-induced Ca(2+) response, wh

266 fically, ketamine tended to downregulate the adenosine triphosphate (ATP)/adenosine diphosphate (ADP)

267 ic machinery for hydrolysis of extracellular adenosine triphosphate and nicotinamide adenine dinucleo

268 xylic acids to aldehydes using the cofactors adenosine triphosphate and nicotinamide adenine dinucleo

269 r neurons-acetylcholine and a combination of adenosine triphosphate and nitric oxide, respectively.

270 l lumen via the sterol-exporting heterodimer adenosine triphosphate binding cassette subfamily G memb

271 Sperm motility is powered by adenosine triphosphate but the relative importance of la

272 pressed in liver facilitating the release of adenosine triphosphate from hepatocytes.

273 that adopts two distinct folds, and the post-adenosine triphosphate hydrolysis state of KaiC create a

274 ae condensin is a molecular motor capable of adenosine triphosphate hydrolysis-dependent translocatio

275 asmid segregation events by stimulating ParF adenosine triphosphate hydrolysis.

276 Within the liver vasculature, adenosine triphosphate is converted into pyrophosphate,

277 diac energetic status (phosphocreatine/gamma-adenosine triphosphate ratio, 1.3+/-0.1 versus 1.9+/-0.1

278 ly discovered that absence of ABCC6-mediated adenosine triphosphate release from the liver and conseq

279 gnificantly impairs platelet aggregation and adenosine triphosphate secretion induced by numerous ago

280 and IL18; cells were incubated with LPS and adenosine triphosphate to activate the NLRP3 complex.

281 e leaving group of the native substrate with adenosine triphosphate, enabling sensitive detection via

282 By characterization of a Petunia hybrida adenosine triphosphate-binding cassette (ABC) transporte

283 in; KCNN4, the Gardos channel; and ABCB6, an adenosine triphosphate-binding cassette family member, i

284 JNK1 or JNK2 or treatment with JNK-IN-8, an adenosine triphosphate-competitive irreversible pan-JNK

285 d threaded through the helicase domain in an adenosine triphosphate-dependent manner.

286 eltapsi-driven presequence translocation and adenosine triphosphate-driven import motor activity.

287 host crucial metabolic pathways and produce adenosine triphosphate.

288 ies on oxidative phosphorylation to generate adenosine triphosphate.

289 ide adenine dinucleotide redox potential and adenosine triphosphate/adenosine diphosphate failed to r

290 that DDX3X, like Ded1p, utilizes exclusively adenosine triphosphates to unwind helices, oligomerizes

291 pha1-, and alpha2- adrenergic receptors, and adenosine type 1 receptor (A1R), tethered to Galphas-XL,

292 gene HP1522 in strain 26695, encodes a N(6)-adenosine type III DNA methyltransferase.

293 an isothiazolo[4,3-d]pyrimidine analogue of adenosine ((tz) A), was developed.

294 hways converging in the formation of AMP and adenosine via CD73.

295 der hypercapnia was 2.1 +/- 0.9 mL/min/g and adenosine was 2.2 +/- 1.1 mL/min/g; these were significa

296 ified with carboxymethyl-cytosine instead of adenosine was described, but no biological activity of t

297 a transvenous pacing catheter was placed and adenosine was given following a dose-escalation protocol

298 MBF after the administration of adenosine was significantly greater than that with the m

299 ly significant asystole (>/=12 seconds after adenosine) was quantified.

300 munostimulatory ATP versus immunosuppressive adenosine within the tumor microenvironment.